Payment overview · 2025
General Payments
$368.98
2 reported records · 1 companies
Healthcare provider profile · identity verified
Paul Chen, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · RIALTO, CA · NPI 1588689350
Verified facts
What the public records show
CMS Open Payments records show Paul Chen, M.D. received $368.98 in general payments during 2025 across 2 reported records.
BIOTISSUE HOLDINGS INC. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | Unresolved — no canonical attribution shown | $368.98 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $368.98 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1130 | 358 |
| Metformin Hcl | Metformin Hcl | 803 | 227 |
| Lisinopril | Lisinopril | 737 | 229 |
| Amlodipine Besylate | Amlodipine Besylate | 705 | 218 |
| Omeprazole | Omeprazole | 457 | 146 |
| Hydrochlorothiazide | Hydrochlorothiazide | 439 | 130 |
| Losartan Potassium | Losartan Potassium | 400 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 377 | 103 |
| Simvastatin | Simvastatin | 358 | 101 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 332 | 75 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 312 | 50 |
| Gabapentin | Gabapentin | 286 | 87 |
| Tamsulosin Hcl | Tamsulosin Hcl | 271 | 81 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 237 | 46 |
| Diclofenac Sodium | Diclofenac Sodium | 224 | 86 |
| Glipizide | Glipizide | 214 | 61 |
| Pioglitazone Hcl | Pioglitazone Hcl | 210 | 62 |
| Pantoprazole Sodium | Pantoprazole Sodium | 202 | 69 |
| Citalopram Hbr | Citalopram Hydrobromide | 194 | 58 |
| Alendronate Sodium | Alendronate Sodium | 180 | 57 |
| Hydralazine Hcl | Hydralazine Hcl | 180 | 56 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 177 | 57 |
| Januvia | Sitagliptin Phosphate | 173 | 41 |
| Trazodone Hcl | Trazodone Hcl | 171 | 47 |
| Furosemide | Furosemide | 167 | 52 |
| Glimepiride | Glimepiride | 165 | 51 |
| Ibuprofen | Ibuprofen | 162 | 62 |
| Metoprolol Succinate | Metoprolol Succinate | 151 | 47 |
| Carvedilol | Carvedilol | 149 | 51 |
| Baclofen | Baclofen | 143 | 48 |
| Atenolol | Atenolol | 129 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 128 | 24 |
| Tramadol Hcl | Tramadol Hcl | 123 | 35 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 117 | 52 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 109 | 21 |
| Benazepril Hcl | Benazepril Hcl | 100 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 100 | 33 |
| Ozempic | Semaglutide | 99 | 21 |
| Potassium Chloride | Potassium Chloride | 99 | 26 |
| Sertraline Hcl | Sertraline Hcl | 99 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 97 | 30 |
| Pregabalin | Pregabalin | 94 | 28 |
| Finasteride | Finasteride | 93 | 30 |
| Enalapril Maleate | Enalapril Maleate | 84 | 27 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 81 | 17 |
| Lorazepam | Lorazepam | 76 | 20 |
| Farxiga | Dapagliflozin Propanediol | 71 | 17 |
| Famotidine | Famotidine | 70 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 70 | 24 |
| Amitriptyline Hcl | Amitriptyline Hcl | 69 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 66 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 64 | 23 |
| Donepezil Hcl | Donepezil Hcl | 63 | 19 |
| Xarelto | Rivaroxaban | 59 | 11 |
| Nifedipine Er | Nifedipine | 57 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 56 | 17 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 56 | 11 |
| Clonidine Hcl | Clonidine Hcl | 55 | 18 |
| Lovastatin | Lovastatin | 55 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 55 | 15 |
| Prednisone | Prednisone | 54 | 16 |
| Allopurinol | Allopurinol | 52 | 16 |
| Alcohol Pads | Alcohol Antiseptic Pads | 51 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 50 | 13 |
| Eliquis | Apixaban | 50 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 40 |
| Methocarbamol | Methocarbamol | 47 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 46 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 46 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 46 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 45 | 11 |
| Temazepam | Temazepam | 44 | 11 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 43 | 14 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 42 | 16 |
| Ketoconazole | Ketoconazole | 41 | 14 |
| Jardiance | Empagliflozin | 40 | 15 |
| Meclizine Hcl | Meclizine Hcl | 40 | 15 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 40 | 14 |
| Naproxen | Naproxen | 40 | 21 |
| Alogliptin | Alogliptin Benzoate | 39 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 16 |
| Propranolol Hcl | Propranolol Hcl | 37 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 36 | suppressed |
| Meloxicam | Meloxicam | 35 | 12 |
| Tradjenta | Linagliptin | 34 | suppressed |
| Trulicity | Dulaglutide | 34 | suppressed |
| Alprazolam | Alprazolam | 33 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Memantine Hcl | Memantine Hcl | 30 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 30 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 29 | suppressed |
| Spironolactone | Spironolactone | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Cephalexin | Cephalexin | 22 | 20 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 22 | suppressed |
| Azithromycin | Azithromycin | 21 | 17 |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Methimazole | Methimazole | 21 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 19 | suppressed |
| Easy Comfort Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 18 | suppressed |
| Glipizide Er | Glipizide | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Insulin Lispro | Insulin Lispro | 17 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Ibu | Ibuprofen | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 15 |
| Buspirone Hcl | Buspirone Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Invokana | Canagliflozin | 14 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Acarbose | Acarbose | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $368.98 · 2 records | BIOTISSUE HOLDINGS INC. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error